Headache

In medicine a headache or cephalalgia is a symptom of a number of different conditions of the head. Some of the causes are benign while others are medical emergencies.

Does the Location of a Headache Matter?

The location of a headache may be an important factor in identifying the cause of certain types of headaches, but not in all.

What is Muscle Contraction Headache?

Headache Evaluation in Children and Teenagers

Headache Behind the Eyes: Understanding the Causes

Frequent Headaches after a Traumatic Brain Injury

Can Contact Lenses Cause Headaches?

Cluster Headaches: Treatment and Prevention

What is Medication Overuse Headache?

Biofeedback Therapy for Headaches

Migraine with Aura vs. Migraine without Aura

Headache Related to Eye Problems

Headaches in Children and Teenagers

Latest Headache News and Research

Medical cannabis compound alleviates nightmares associated with PTSD

Nightmares are among the most agonizing symptoms of post-traumatic stress disorder (PTSD) – a condition that can develop after exposure to severe traumatic experiences, such as disasters, serious accidents, acts of violence, or wartime experiences. Individuals affected relive the events intensely at night, as if they were real, time and time again.

5 Aug 2026

Psilocybin trial shows striking remission rates for veterans with PTSD

The first U.S. clinical trial of psilocybin-assisted therapy in veterans with PTSD who got no relief from conventional treatments has established that the protocol is safe, causing no serious adverse events or increases in suicidal thinking or behavior.

30 Jul 2026

ALS risk varies significantly across U.S. military service branches

Compared to Army veterans, men who are veterans of the U.S. Air Force, Navy and Coast Guard have higher rates of amyotrophic lateral sclerosis (ALS), and men who are Marine veterans have lower rates, according to a new study published July 29, 2026, in Neurology®, an official journal of the American Academy of Neurology.

29 Jul 2026

Early-life sugar restriction may reduce dementia risk later

Consuming less sugar in utero before birth and during the first one to two years of life was associated with a lower risk of developing dementia later in life, according to a study published July 29, 2026, in Neurology, the medical journal of the American Academy of Neurology.

29 Jul 2026

Deramiocel cell therapy slows muscle and heart damage in advanced DMD

A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy (DMD), and may also slow heart damage in those who already have heart muscle disease, a phase 3 clinical trial published in The Lancet has found.

29 Jul 2026

Plasma exchange improves recovery in rare inflammatory nerve disease

Plasma exchange can help treat people with a rare inflammatory disease that can cause blindness, according to a systematic review and meta-analysis published on July 22, 2026, in Neurology, the medical journal of the American Academy of Neurology.

22 Jul 2026

Multiple sclerosis deaths occur earlier among Black patients

Black people with multiple sclerosis (MS) die from MS at a younger age than white people, with a peak mortality rate at ages 65 to 74 for Black people and ages 75 to 84 for white people, according to a study published July 22, 2026, in Neurology® Open Access, an official journal of the American Academy of Neurology.

22 Jul 2026

Foreign-born Black adults show lower stroke risk than Americans

For Black individuals in the United States, being born in another country was associated with a lower risk of stroke, according to a study published July 15, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

15 Jul 2026

Irritable patients changed physicians’ emotions but not decisions

Irritable patient behavior influences physician emotions but does not alter clinical assessments, emphasizing the need for emotional resilience training.

15 Jul 2026

High physician knowledge scores linked to lower healthcare costs

Patients whose physicians scored higher in the first year of the American Board of Internal Medicine's (ABIM) Internal Medicine Longitudinal Knowledge Assessment (LKA) were significantly less likely to receive low-value healthcare services, which cumulatively cost the U.S. healthcare system an estimated $100 billion each year.

13 Jul 2026

Rising tick-borne disease in Canada can trigger heart inflammation

Move over, Lyme disease - there's another tick-borne disease to worry about in Canada. Anaplasmosis, the second most common tick-borne disease in the country, can cause a range of health issues, including myocarditis (inflammation of the heart muscle).

13 Jul 2026

Robot-guided surgery successfully drains multiple deep brain abscesses

Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery. Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery.

13 Jul 2026

Ear acupuncture may reduce migraine pain, study suggests

Acupuncture to the ear may help to lessen pain from migraines and their impact on daily life, according to new research presented today (Friday) at the Federation of European Neuroscience Societies (FENS) Forum 2026.

9 Jul 2026

Early-onset dementia lowers work productivity years before formal diagnosis

People diagnosed with early-onset dementia had reduced work productivity up to 15 years before diagnosis, according to a study published July 8, 2026, in Neurology, the medical journal of the American Academy of Neurology.

9 Jul 2026

Researchers identify a distinct subtype of eosinophilic esophagitis in children

Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago identified a distinct subtype of eosinophilic esophagitis (EoE) – a chronic allergic inflammatory disorder in which the esophagus narrows, interfering with food going down properly.

6 Jul 2026

Genetic testing could sharply increase demand for ALS specialist care

The availability of genetic testing for amyotrophic lateral sclerosis (ALS) for people with a family member diagnosed with the disease is expected to greatly increase the number of clinic visits to specialized ALS centers over the next decade, according to a study published June 24, 2026, in Neurology Genetics, an official journal of the American Academy of Neurology.

24 Jun 2026

Trial identifies 4 grams a day as the tested safe level for L-tyrosine in healthy men

A randomized, crossover trial in healthy adult men found that 4 weeks of L-tyrosine supplementation at doses up to 4 g/day did not cause clinically meaningful changes in safety markers, diet, blood pressure, or body measures. The highest tested dose, 4 g/day, was identified as the no-observed-adverse-effect level under the study’s four-week conditions, although broader and longer-term studies are still needed.

23 Jun 2026